IP Library Granted Patent US 10,563,163
Granted Patent B2
US 10,563,163 · App. 15/322,560 · Granted Feb 18, 2020

Cross-scale modeling of bioreactor cultures using Raman spectroscopy

Inventors: Brandon Berry (Boston, MA); Justin Moretto (Apex, NC)
Assignee: Biogen MA Inc.
C12M41/32C12M41/48G01N21/65G01N2201/12
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,563,163
App. No.
15/322,560
Granted
Feb 18, 2020
Kind
B2
Abstract

Aspect of the disclosure relate to methods of assessing a bioreactor culture that involve determining a culture parameter of the manufacturing-scale bioreactor culture using a model that relates a Raman spectrum to the culture parameter. Related bioreactor system are also provided.

Claims (102)

1. A method of assessing a bioreactor culture, the method comprising:

(i) obtaining a Raman spectrum of a manufacturing-scale bioreactor culture using a probe configured inline with the bioreactor; and

(ii) determining a culture parameter of the manufacturing-scale bioreactor culture using a multivariate partial least squares (PLS) model that relates the Raman spectrum to the culture parameter, wherein the model was developed based on one or more test bioreactor cultures;

wherein the working volume of the manufacturing-scale bioreactor culture is in a range of 1,000 L to 100,000 L;

wherein the working volumes of the one or more test bioreactor cultures are in a range of 0.1 L to 100 L;

wherein the model was built from spectral data collected during fed-batch cell culture processing from the one or more test bioreactor cultures by exporting the data from one or more respective Raman probes; and

wherein each of the one or more Raman probes is configured for obtaining a Raman spectrum of the respective bioreactor culture during cell growth.

2. The method of claim 1 , wherein

(i) the test bioreactor culture is in a range of 1 L to 5 L; and/or

(ii) the test bioreactor culture is is in a range of 50 L to 100 L.

3. The method of claim 1 , wherein the culture parameter is a level of glucose, glutamate, ammonia or lactate in the culture.

4. The method of claim 3 , wherein

(a) the culture parameter is a level of glucose, and wherein the model has:

(i) a root mean square error of estimation in a range of 0.50 g/L to 1 g/L, and/or

(ii) a root mean square error of cross validation in a range of 0.50 g/L to 1 g/L, and/or

(iii) a root mean square error of prediction in a range of 0.50 g/L to 1.5 g/L, and/or

(iv) an average percentage error of up to 10%;

(b) the culture parameter is a level of lactate, and wherein the model has:

(i) a root mean square error of estimation in a range of 0.10 g/L to 0.20 g/L, and/or

(ii) a root mean square error of cross validation in a range of 0.10 g/L to 0.20 g/L, and/or

(iii) a root mean square error of prediction in a range of 0.10 g/L to 0.20 g/L, and/or

(iv) an average percentage error of up to 20%;

(c) the culture parameter is a level of glutamate, and wherein the model has;

(i) a root mean square error of estimation in a range of 0.10 mM to 0.20 mM, and/or

(ii) a root mean square error of cross validation in a range of 0.10 mM to 0.40 mM, and/or

(iii) a root mean square error of prediction in a range of 0.40 mM to 1.5 mM, and/or

(iv) an average percentage error of up to 35%; or

(d) the culture parameter is a level of ammonium, and wherein the model has:

(i) a root mean square error of estimation in a range of 0.20 mM to 0.40 mM, and/or

(ii) a root mean square error of cross validation in a range of 0.20 mM to 0.50 mM, and/or

(iii) a root mean square error of prediction in a range of 0.40 mM to 1.5 mM, and/or

(iv) an average percentage error of up to 20%.

5. The method of claim 1 , wherein the culture parameter is the osmolality of the culture.

6. The method of claim 5 , wherein the model has:

(i) a root mean square error of estimation in a range of 5 mOsm/kg to 15 mOsm/kg, and/or

(ii) a root mean square error of cross validation in a range of 10 mOsm/kg to 15 mOsm/kg, and/or

(iii) a root mean square error of prediction in a range of 10 mOsm/kg to 25 mOsm/kg, and/or

(iv) an average percentage error of up to 10%.

7. The method of claim 1 , wherein the volume of the manufacturing-scale bioreactor culture is in a range of 2000 L to 20000 L.

8. The method of claim 1 , wherein the volume of the manufacturing-scale bioreactor culture is in a range of 2000 L to 15000 L.

9. A method comprising:

(i) obtaining a Raman spectrum of a first bioreactor culture of a first volume using a probe configured inline with the bioreactor; and

(ii) determining a culture parameter of the first bioreactor culture using a multivariate partial least squares (PLS) model, which model was developed based on a second bioreactor culture of a second volume, that relates the Raman spectrum to the culture parameter, wherein the second volume is in a range of 0.1% to 10% of the first volume;

wherein the model was built from spectral data collected during fed-batch cell culture processing from the one or more test bioreactor cultures by exporting the data from one or more respective Raman probes; and

wherein each of the one or more Raman probes is configured for obtaining a Raman spectrum of the respective bioreactor culture during cell growth.

10. The method of claim 1 , wherein the model was further developed based on at least one bioreactor culture of substantially the same volume as the manufacturing-scale bioreactor culture.

11. The method of claim 1 , wherein

(i) the Raman spectrum comprises spectral signal in the 200cm- 1 to 3400cm- 1 wavenumber range;

(ii) the Raman spectrum comprises spectral signal in the visible, near infrared, infrared, near ultraviolet, or ultraviolet (UV) range;

(iii) the Raman spectrum is obtained using Surface Enhanced Raman Spectroscopy (SERS), resonance Raman spectroscopy, tip-enhanced Raman spectroscopy, polarized Raman spectroscopy, stimulated Raman spectroscopy, transmission Raman spectroscopy, spatially offset Raman spectroscopy, difference Raman spectroscopy, Fourier Transform (FT) Raman spectroscopy, or hyper Raman spectroscopy; and/or

(iv) the Raman spectrum is obtained using a Raman analyzer configured with a laser or other suitable light source configured to operate at wavelengths in a range of 325 nm to 1064 nm.

12. A bioreactor system comprising:

a bioreactor chamber configured for containing a manufacturing-scale bioreactor culture;

a probe configured for obtaining a Raman spectrum of the manufacturing-scale bioreactor culture; and

a computer configured for determining a culture parameter of the manufacturing-scale bioreactor culture, wherein the computer comprises:

an input interface configured to receive information indicative of the Raman spectrum obtained from the probe;

at least one processor programmed to evaluate a model that relates the Raman spectrum to the culture parameter, wherein the model was developed based on one or more test bioreactor cultures, and

an output interface configured to output a signal indicative of the determined culture parameter;

wherein the working volume of the manufacturing-scale bioreactor culture is in a range of 1,000 L to 100,000 L;

wherein the working volumes of the one or more test bioreactor cultures are in a range of 0.1 L to 100 L;

wherein the model was built from spectral data collected during fed-batch cell culture processing from the one or more test bioreactor cultures by exporting the data from one or more respective Raman probes; and

wherein each of the one or more Raman probes is configured for obtaining a Raman spectrum of the respective bioreactor culture during cell growth.

13. The bioreactor system of claim 12 , wherein the output comprises a feedback control signal for controlling operation of a device for altering the culture parameter or wherein the device for altering the culture parameter is a pump or valve configured to control flow, into or out from the bioreactor culture, of a medium comprising one or more culture components.

14. The bioreactor system of claim 12 , wherein

(i) the test bioreactor culture is in a range of 1 L to 5 L; and/or

(ii) the test bioreactor culture is in a range of 50 L to 100 L; and/or

(v) the model is a partial least squares model.

15. The bioreactor system claim 12 , wherein the culture parameter is a level of glucose, glutamate, ammonia or lactate in the culture, or wherein the culture parameter is the osmolality of the culture.

16. The bioreactor system of claim 12 , wherein

(a) the culture parameter is a level of glucose, and wherein the model has:

(i) a root mean square error of estimation in a range of 0.50 g/L to 1 g/L, and/or

(ii) a root mean square error of cross validation in a range of 0.50 g/L to 1 g/L, and/or

(iii) a root mean square error of prediction in a range of 0.50 g/L to 1.5 g/L, and/or

(iv) an average percentage error of up to 10%;

(b) the culture parameter is a level of lactate, and wherein the model has:

(i) a root mean square error of estimation in a range of 0.10 g/L to 0.20 g/L, and/or

(ii) a root mean square error of cross validation in a range of 0.10 g/L to 0.20 g/L, and/or

(iii) a root mean square error of prediction in a range of 0.10 g/L to 0.20 g/L, and/or

(iv) an average percentage error of up to 20%;

(c) the culture parameter is a level of glutamate, and wherein the model has

(i) a root mean square error of estimation in a range of 0.10 mM to 0.20 mM, and/or

(ii) a root mean square error of cross validation in a range of 0.10 mM to 0.40 mM, and/or

(iii) a root mean square error of prediction in a range of 0.40 mM to 1.5 mM, and/or

(iv) an average percentage error of up to 35%; and/or

(d) the culture parameter is a level of ammonium, and wherein the model has:

(i) a root mean square error of estimation in a range of 0.20 mM to 0.40 mM, and/or

(ii) a root mean square error of cross validation in a range of 0.20 mM to 0.50 mM, and/or

(iii) a root mean square error of prediction in a range of 0.40 mM to 1.5 mM, and/or

(iv) an average percentage error of up to 20%.

17. The bioreactor system of claim 12 , wherein the culture parameter is the osmolality of the culture and the model has:

(i) a root mean square error of estimation in a range of 5 mOsm/kg to 15 mOsm/kg, and/or

(ii) a root mean square error of cross validation in a range of 10 mOsm/kg to 15 mOsm/kg, and/or

(iii) a root mean square error of prediction in a range of 10 mOsm/kg to 25 mOsm/kg, and/or

(iv) an average percentage error of up to 10%.

18. The bioreactor system of claim 12 , wherein

(i) the Raman spectrum comprises spectral signal in the 200cm- 1 to 3400cm-1 wavenumber range;

(ii) the Raman spectrum comprises spectral signal in the visible, near infrared, infrared, near ultraviolet, or ultraviolet (UV) range;

(iii) the Raman spectrum is obtained using Surface Enhanced Raman Spectroscopy (SERS), resonance Raman spectroscopy, tip-enhanced Raman spectroscopy, polarized Raman spectroscopy, stimulated Raman spectroscopy, transmission Raman spectroscopy, spatially offset Raman spectroscopy, difference Raman spectroscopy, Fourier Transform (FT) Raman spectroscopy, or hyper Raman spectroscopy; and/or

(iv) the probe comprises a Raman analyzer configured with a laser or other suitable light source configured to operate at wavelengths in a range of 325 nm to 1064 nm.

19. The bioreactor system of claim 12 , wherein the model was further developed based on at least one bioreactor culture of substantially the same volume as the manufacturing-scale bioreactor culture.

20. The method of claim 12 , wherein the volume of the manufacturing-scale bioreactor culture is in a range of 2000 L to 20000 L.

21. The method of claim 12 , wherein the volume of the manufacturing-scale bioreactor culture is in a range of 2000 L to 15000 L.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 26, 2017
From: BERRY, BRANDON; MORETTO, JUSTIN
To: BIOGEN MA INC.
Reel/Frame 043097/0467 →
Continuity (3)
Provisional Application 62020371 · Jul 2, 2014
Related Publication 20170130186A1 · May 11, 2017
Related Publication 20170355947A9 · Dec 14, 2017
Cited By (3)
US 12,372,470 US 12,398,176 US 12,516,280